Physician profile
Patrick J Mcfadden
NPI 1841202488
$907.91
in general payments reported to CMS, 2019-2025
10 companies · $286 in 2025
The $286 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $63.10 · 2022: $21.47 · 2023: $332 · 2024: $69.36 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $210.44 | 2022-2025 | Grafix Pl, Oasis, Collagenase Santyl |
| Organogenesis INC. | $173.65 | 2019-2020 | |
| Kci USA, INC. | $150.53 | 2019-2023 | Activ.A.C. Ion Progress, V.A.C. Veraflo, Promogran Prisma |
| Cashflow Solutions, LLC | $84.70 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Reprise Biomedical, INC. | $71.61 | 2023 | Miro3d |
| Kerecis Limited | $69.59 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Molnlycke Health Care US, LLC | $56.21 | 2023-2025 | Exufiber, Mepilex Border Flex, Mepitel One |
| Convatec INC. | $43.03 | 2024 | |
| Next Science LLC | $32.27 | 2023 | Xperience, Blastx, Surgx |
| Medtronic, INC. | $15.88 | 2025 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcfadden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.